Phase Ib/II Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
Conditions: Hepatocellular Carcinoma Interventions: Drug: Valemetostat; Drug: Atezolizumab; Drug: Bevacizumab Sponsors: University of Alabama at Birmingham Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Research | Study